22 employees
Nura Bio revolutionizes the treatment of neurological diseases with novel, life-changing neuroprotective medicines.
2018
$73M
from 2 investors over 2 rounds
Nura Bio raised $73M on July 29, 2020
Investors: Samsara BioCapital and The Column Group